[{"address1": "3710 \u2013 33rd Street NW", "city": "Alberta Beach", "state": "AB", "zip": "T2L 2M1", "country": "Canada", "phone": "403 455 7727", "website": "https://www.xortx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, pre-diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, a program to treat acute kidney injury (AKI) associated with respiratory virus infection and associated health consequences; and XRX-225, a program for treatment of type 2 diabetic nephropathy. It has a collaboration and license agreements with the Icahn School of Medicine; and a license agreement with the University of Florida Research Foundation, Inc. The company is based in Alberta Beach, Canada.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Dr. Allen Warren Davidoff Ph.D.", "age": 63, "title": "Founder, CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 286969, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James Neville Fairbairn C.A., C.P.A., ICD.D", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 56659, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Haworth M.D., MRCP", "age": 73, "title": "Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2023, "totalPay": 159621, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stacy  Evans M.B.A., M.D.", "age": 49, "title": "Chief Business Officer", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 208194, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nick  Rigopoulos", "title": "Director of Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Sans M.B.A., Ph.D.", "age": 54, "title": "Director of Corporate Development", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  MacDonald Ph.D.", "age": 59, "title": "Consultant of Clinical Operations", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Charlotte  May", "title": "Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.89, "open": 0.945, "dayLow": 0.87, "dayHigh": 0.945, "regularMarketPreviousClose": 0.89, "regularMarketOpen": 0.945, "regularMarketDayLow": 0.87, "regularMarketDayHigh": 0.945, "beta": -0.207, "trailingPE": 7.406667, "forwardPE": -0.5322156, "volume": 30865, "regularMarketVolume": 30865, "averageVolume": 109733, "averageVolume10days": 30460, "averageDailyVolume10Day": 30460, "marketCap": 2865100, "fiftyTwoWeekLow": 0.85, "fiftyTwoWeekHigh": 7.0, "fiftyDayAverage": 1.11558, "twoHundredDayAverage": 1.702955, "currency": "USD", "enterpriseValue": 744154, "floatShares": 2660333, "sharesOutstanding": 3223560, "sharesShort": 2238, "sharesShortPriorMonth": 31275, "sharesShortPreviousMonthDate": 1727654400, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.0007, "heldPercentInsiders": 0.03016, "heldPercentInstitutions": 0.06032, "shortRatio": 0.02, "shortPercentOfFloat": 0.0007, "impliedSharesOutstanding": 3440540, "bookValue": 2.322, "priceToBook": 0.3827735, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -1483012, "trailingEps": 0.12, "forwardEps": -1.67, "lastSplitFactor": "1:9", "lastSplitDate": 1699920000, "enterpriseToEbitda": -0.225, "52WeekChange": -0.6212766, "SandP52WeekChange": 0.21142256, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "XRTX", "underlyingSymbol": "XRTX", "shortName": "XORTX Therapeutics Inc.", "longName": "XORTX Therapeutics Inc.", "firstTradeDateEpochUtc": 1632403800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ccf511eb-7240-3e07-af90-4d0cc6586c46", "messageBoardId": "finmb_259860883", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.8888, "recommendationKey": "none", "totalCash": 3078472, "totalCashPerShare": 1.06, "ebitda": -3303909, "totalDebt": 83706, "quickRatio": 7.082, "currentRatio": 7.665, "debtToEquity": 3.095, "returnOnAssets": -0.33139, "returnOnEquity": -0.29358998, "freeCashflow": -1847076, "operatingCashflow": -4409178, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-08"}]